Webinar: Changing the paradigm for colorectal cancer - Clinical practice & drug development

Many ongoing studies aim to improve treatment and outcomes for early-stage colorectal cancer, including guiding adjuvant chemotherapy decisions and bringing targeted therapies and immunotherapies into the early-stage setting. Join us for a webinar and panel discussion on the ways in which the paradigm for colorectal cancer care is changing, particularly in the context of the latest 2022 data from ESMO, ASCO, and ASCO GI.